Patent · US Active

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

US8778671B2 · kind B2 · utility

3Cited by

1References

6Claims

0Family size

Assignees

The United States of America as Represented by the Secretary of the Department of Health and Human Services · US
The Walter Reed Army Institute of Research · US

Inventors

Alexander G. Pletnev · Rockville, US
Joseph R. Putnak · Silver Spring, US
Robert M. Chanock · Bethesda, US
Brian R. Murphy · Bethesda, US
Stephen S. Whitehead · Montgomery Village, US
Joseph E. Blaney · Frederick, US

Key dates

Filing date	Jun 18, 2004
Grant date	Jul 15, 2014
Priority date	—
Expiry date	Dec 14, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to attenuated, immunogenic West Nile virus chimeras built on a dengue virus backbone for the production of immunogenic, live, attenuated West Nile virus vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.